Početna › Veliki depresivni poremećaj › Illinois
Kliničke studije za Veliki depresivni poremećaj u državi Illinois
20 studija za Veliki depresivni poremećaj traži sudionike na lokacijama u državi Illinois.
Gradovi u državi Illinois
Službeni tekst studije (engleski)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Charter Research - Chicago, Chicago
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Chicago Research Center, Chicago
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Northwestern University, Chicago
- Baber Research Group, Naperville
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Chicago Research Center, Chicago
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07621237A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Endeavor Health Evanston Hospital, Evanston
U tijeku regrutacijaFaza 3
Od 12 do 17 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07227454A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Rush University, Chicago
U tijeku regrutacijaFaza 3
Od 18 do 85 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Chicago
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Naperville
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 18. ruj 2026. · NCT07105111A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Advanced Quality Medical Research, Orland Park
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Chicago
- Draig Clinical Site, Skokie
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Rush University Medical Center, Chicago
U tijeku regrutacija
Od 22 do 70 godina · Oba spola · Ažurirano 28. kol 2026. · NCT06423430A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Uptown Research Institute, Chicago
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 10. kol 2026. · NCT07592689A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- EmVenio Research, Chicago
U tijeku regrutacijaFaza 2
Od 18 do 64 godina · Oba spola · Ažurirano 27. srp 2026. · NCT07115329Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Chicago
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 24. srp 2026. · NCT07484217A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Flourish Research - Great Lakes Clinical Trials /ID# 278201, Chicago
- Amr Conventions Research /ID# 277547, Warrenville
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 15. lip 2026. · NCT07276997Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
- University of Illinois at Chicago, Chicago
U tijeku regrutacija
Od 18 do 64 godina · Oba spola · Ažurirano 4. lip 2026. · NCT05051618A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Pillar Clinical Research LLC, Chicago
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 11. svi 2026. · NCT06524830Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Chicago Medical Center, Chicago
U tijeku regrutacijaOpažajna studija
Od 18 do 40 godina · Oba spola · Ažurirano 10. ožu 2026. · NCT06740383Study of ALTO-300 in MDD
- Site 310, Chicago
U tijeku regrutacijaFaza 2
Od 18 do 70 godina · Oba spola · Ažurirano 24. srp 2025. · NCT05922878A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Chicago
U tijeku regrutacijaFaza 4
Od 18 do 65 godina · Oba spola · Ažurirano 23. sij 2025. · NCT06223880Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.